Medifast, Inc., the parent company of Trilivy, has established the Medifast Metabolic Health Institute, bringing rigorous research and evidence-based education to its approach to metabolic health. Through the institute, Medifast will gather its clinical research, scientific expertise and educational resources under a single body to support its belief that everyone deserves access to the science, education, tools and support necessary to achieve optimal metabolic health.

Medifast announced its financial results for the second quarter of 2026. Revenue during the quarter was $76.4 million, a 27.6% decrease from Q2 2025, with a net loss of $3.1 million, or $0.28 per diluted share.

Medifast, the parent company of OPTAVIA, debuted Trilivy, a comprehensive metabolic health system designed to support healthy lifestyle change. Included in the launch is the Trilivy Reset Fueling line, an array of new meal replacement options formulated with proprietary ingredients to support key metabolic pathways, normal fat metabolism and healthy insulin function. Trilivy is structured […]

Medifast, the parent company of direct selling organization OPTAVIA, announced its financial results for the first quarter of 2026. Revenue during the quarter was $76 million with a net loss of $2.1 million, or $0.19 per diluted share. Independent active earning coaches totaled 14,000 and had an average revenue per active earning coach of $5,432.

Medifast announced its financial results for the fourth quarter and full year 2025. Revenue during the fourth quarter reached $75.1 million while full-year 2025 revenue totaled $385.8 million.

Medifast, the parent company for OPTAVIA, announced its financial results for the third quarter of 2025. Revenue during the quarter fell 36.2% to $89.4 million, which the company attributed to a decrease in the number of active earning OPTAVIA coaches. Total active earning OPTAVIA coaches declined 35% from 30,000 in Q3 2024 to 19,500 in […]

Medifast, the parent company of direct selling organization OPTAVIA, announced a new focus on holistic metabolic health. This transformation will begin with its recently introduced Metabolic Synchronization, a system designed to reverse metabolic dysfunction with a “targeted reset” of the body’s metabolism.

An analysis of data from Medifast, the parent company of direct selling organization OPTAVIA, from their clinical trial showed that those using the company’s Optimal Weight 5 & 1 plan preserved 98% of lean mass after 16 weeks on the program. These new findings support Medifast’s original goal of supporting metabolic health beyond simply driving weight loss.

Medifast, the parent company of direct selling organization OPTAVIA, announced its financial results for the second quarter of 2025. Revenue during the quarter fell 37.4% year-over-year to $105.6 million, which the company said was primarily driven by a decrease in the number of active earning OPTAVIA coaches.

Medifast, the parent company of OPTAVIA, reported its financial results for the first quarter of 2025. Revenue during the quarter was $115.7 million, a 33.8% decrease from the same period in 2024.

Medifast announced its financial results for the fourth quarter and full year 2024. Revenue during the fourth quarter was $119 million, with a revenue per active earning coach of $4,391.

Medifast announced its financial results for the fourth quarter and full year 2024. The parent company for direct selling organization OPTAVIA, Medifast reported fourth quarter revenue of $119 million.